Back to Search
HELMY SIRAGY, M.D.
M.D.
Endocrinology, Diabetes & Metabolism Physician
NPI: 1316082290IndividualAccepts Medicare
Specialties, Licenses & Credentials
Endocrinology, Diabetes & Metabolism PhysicianPrimary
Internal Medicine — Endocrinology, Diabetes & Metabolism
Code: 207RE0101X
0101037051(VA)
Education
OTHER
Class of 1976
Research & Publications (20)
The potential role of the angiotensin subtype 2 receptor in cardiovascular protection.
PMID 19602326·Curr Hypertens Rep·2009
6-review
The development of the direct renin inhibitor aliskiren: treating hypertension and beyond.
PMID 18764720·Expert Opin Emerg Drugs·2008
6-review
Evidence for benefits of angiotensin receptor blockade beyond blood pressure control.
PMID 18625154·Curr Hypertens Rep·2008
6-review
Local renal aldosterone production induces inflammation and matrix formation in kidneys of diabetic rats.
PMID 18296490·Exp Physiol·2008
7-preclinical
Renal (pro)renin receptor upregulation in diabetic rats through enhanced angiotensin AT1 receptor and NADPH oxidase activity.
PMID 18192338·Exp Physiol·2008
7-preclinical
Angiotensin AT1 and AT2 receptors--the battle for health and disease.
PMID 17951304·Nephrol Dial Transplant·2007
8-other
Renin inhibition: a new modality for hypertension management.
PMID 17686379·Curr Hypertens Rep·2007
6-review
NO and cGMP mediate angiotensin AT2 receptor-induced renal renin inhibition in young rats.
PMID 17670863·Am J Physiol Regul Integr Comp Physiol·2007
7-preclinical
Beneficial effects of combined benazepril-amlodipine on cardiac nitric oxide, cGMP, and TNF-alpha production after cardiac ischemia.
PMID 16775501·J Cardiovasc Pharmacol·2006
7-preclinical
Angiotensin II compartmentalization within the kidney: effects of salt diet and blood pressure alterations.
PMID 16340666·Curr Opin Nephrol Hypertens·2006
6-review
Clinical trials report. Beta-blockade in diabetes: alleviating the concerns.
PMID 16061039·Curr Hypertens Rep·2005
8-other
Angiotensin subtype-2 receptors inhibit renin biosynthesis and angiotensin II formation.
PMID 15534073·Hypertension·2005
4-observational
AT1 and AT2 receptor in the kidney: role in health and disease.
PMID 15017521·Semin Nephrol·2004
6-review
Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitors or calcium channel blocker vs diuretic. The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).
PMID 12844462·Curr Hypertens Rep·2003
3-trial
The angiotensin II type 1 receptor mediates renal interstitial content of tumor necrosis factor-alpha in diabetic rats.
PMID 12746279·Endocrinology·2003
7-preclinical
Angiotensin receptor blockers: how important is selectivity?
PMID 12441224·Am J Hypertens·2002
6-review
Differences in AT2 -receptor stimulation between AT1 -receptor blockers valsartan and losartan quantified by renal interstitial fluid cGMP.
PMID 12023686·J Hypertens·2002
4-observational
Angiotensin-converting enzyme inhibition potentiates angiotensin II type 1 receptor effects on renal bradykinin and cGMP.
PMID 11509473·Hypertension·2001
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- UVA ENDOCRINOLOGY, 415 RAY C. HUNT DRIVE
CHARLOTTESVILLE, VA 22903 - Phone
- (434) 924-1825
Quick Facts
- NPI
- 1316082290
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 50
- Publications
- 20
Are you this provider?
Claim Your Profile